Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 18 Aug 2005 |
| Genmab, nitiates HuMax®-CD20 Phase II Study in Rheumatoid Arthritis | 16 Aug 2005 |
| Genmab, Grant of Warrants | 10 Aug 2005 |
| Genmab, interim report - six months | 9 Aug 2005 |
| Genmab, Announces 2005 First Half Year Results | 9 Aug 2005 |